One Genomics Secures New Investment from Keio Innovation Initiative
Deal News | Apr 28, 2025 | Keio Innovation Initiative Inc
Keio Innovation Initiative Inc. has announced a new investment in One Genomics, Inc., a company known for its Safeguard gRNA technology. This strategic investment aims to bolster One Genomics' capacity for growth and innovation in the biotechnology and genomics sectors. Keio Innovation Initiative, a prominent private equity firm, is recognized for supporting companies at the forefront of tech and biotech advancements. With this injection of capital, One Genomics is expected to enhance its research and development capabilities, further advancing genomic technologies that have pivotal implications in medical research and therapies.
Sectors
- Biotechnology
- Private Equity
Geography
- Japan – Keio Innovation Initiative Inc. is based in Japan, indicating the geographical focus of the private equity firm and its investment activities.
Industry
- Biotechnology – The article involves One Genomics, a company operating in the biotechnology industry, focusing on genomic technologies and innovation.
- Private Equity – Keio Innovation Initiative Inc., a private equity firm, is the investor providing new funding to One Genomics.
Financials
- Not specified – The article does not specify the exact amount of funding provided by Keio Innovation Initiative to One Genomics.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Keio Innovation Initiative Inc. | Investor | Company | A Japanese private equity firm known for investing in technology and biotech companies. |
| One Genomics, Inc. | Target | Company | A company focused on advancing genomic technologies, known for its Safeguard gRNA technology. |